Navigation Links
Global Bio-Clinical Trials 2012 Just Launched in India!
Date:7/11/2012

BANGALORE, India, July 11, 2012 /PRNewswire/ --

25-28 September, The Lalit Ashok, Bangalore

Today, more and more countries across the globe are dedicated towards developing a favourable environment for the growth of biopharmaceutical and biosimilar products in their respective markets. The Indian regulatory bodies like the DCGI and the ICMR too are constantly revising their norms and standards to promote clinical trials, and eventually the growth of biotech products in the country. This is largely due to the fact that these bio-products are solutions to some of the most dreaded diseases and require high manufacturing and marketing investments.

With these developments in the background, CPhI Conferences is launching Global Bio-Clinical Trials 2012, a highly anticipated strategic 4-day initiative (25-28 September, Bangalore India) focused on the challenges pertaining to conduct of clinical trials for the approval of sensitive biopharmaceuticals and biosimilars drugs. An interactive seminar on 'Emerging Market Regulations - Brazil, China, Russia, LATAM & Malaysia' will take place on 25 September, and an exclusive workshop on PharmacoKinetics/PharmacoDynamics studies on 28 September.

The 2-day conference (26-27 September) will provide solutions to dealing with the current regulatory challenges and guidelines for robust design of clinical trials, economic patient recruitment and retention protocols, latest tool and techniques for clinical data management and medical writing, along with updates on the latest pharmacovigilance trends.

Eminent speakers like Dr Ragunadarao Digumarti (HOD, Oncology, NIZAMS Hyderabad), Mr Solomon Yimam (Assistant Director, Clinical research, US FDA), Mr Scott Laufenberg (Assistant Director(BIMO), US FDA), Dr Arani Chatterjee (VP, Clinical research, Panacea Biotec), Dr YK Gupta (National Scientific Co-ordinator, Pharmacovigilance Programme of India),  Dr Sanjeev Hegde (GM, Clinical Development, Piramal Healthcare), Dr Goutam Pujari (VP, Clinical Research Operations, Glenmark Pharmaceuticals), Dr Deven Parmar (CEO & Medical Director, Karmic Life Sciences), Dr Ajay Gautam (Executive Director and Head of Emerging Markets, AstraneZeneca ,China), Dr Sanish Davis (Director Clinical Pharmacology in Emerging Markets, MSD), Mr Arjun Roy (Head CDM & Biometrics, Ranbaxy) among other industry experts, are already on board providing the latest updates for development of biopharmaceuticals and biosimilars in their respective organisations.

Global Bio-Clinical Trials 2012 will bring together 100+ regulators, heads of clinical research, clinical operations & clinical R&D, pharmacovigilance, medical affairs, clinical aata management and medical doctors from across biopharmaceutical and biosimilars companies across India and the world, to help increase awareness about the latest developments pertaining to clinical trials of bio-products. For more details you can log on to http://www.bioclinicaltrials.com/pr

CPhI India is a UBM brand, and is the largest and most important meeting place for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian Pharma industry.

UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit http://www.ubmindia.in.

For further information please contact:

Ms Asan Bano
Customer Services Executive
CPhI conferences
+91(022)4046-1466
conferences-india@ubm.com



'/>"/>
SOURCE CPhI Conferences India
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinase Inhibitors Market to Reach $11.6 Billion in US, $40.3 Billion Globally by 2016
2. Micross Components Appointed as Global Specialist Die Distributor to International Rectifier
3. Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
4. Sports Medicine Implants Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
5. Medical Diagnostic & Therapeutic Ultrasound Devices Market (2012 - 2017) - Global Trends & Competitive Analysis
6. Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
7. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
8. Marken Launches New Global Regulatory Consultation Services
9. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
10. Clinical Chemistry Market Report & Forecast (2012 - 2015): Global Analysis
11. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
(Date:4/28/2016)... , April 28, 2016 ... , George Phillips und ... Unternehmens    ArisGlobal®, ein führender ... Sciences, gab heute bekannt, dass neue Führungskräfte ... Unternehmens gestoßen sind, die vielfältige Erfahrungen mitbringen. ...
(Date:4/28/2016)... Ind., April 28, 2016 , Net Sales ... reported basis over the prior year period, and an increase ... , Diluted EPS for the first quarter were $0.52 ... and $2.00 adjusted, an increase of 29.9% over the prior ... and adjusted earnings guidance for 2016 Zimmer Biomet ...
Breaking Medicine Technology:
(Date:4/29/2016)... , ... April 29, 2016 , ... In an ... and divorcee, shares her enthusiasm for Botox and lip injections, which she underwent in ... youth oriented Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, ... addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization ... optimization products to the store is just one more way Shamangelic Healing supports ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American workforce is ... even security. Most importantly, employees are the single most important asset in creating ... so unhappy? , Just under half of American workers are emotionally checked out ...
(Date:4/29/2016)... ... 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd annual ... skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers and ... Walk and 1-mile walk were held to increase awareness about Lyme disease and ...
(Date:4/29/2016)... ... 2016 , ... Spine Team Texas, a comprehensive spine physician group specializing in ... physicians has been invited to be a featured speaker at the Texas Society of ... April 30, 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation ...
Breaking Medicine News(10 mins):